Plasmovirus: Replication cycle of a novel nonviral/viral vector for gene transfer

Cancer Gene Therapy

Volumn 4, Issue 5, 1997, Pages 286-293

  Morozov, Vladimir A ^a   Noguiez Hellin, Patricia ^b   Laune, Sylvain ^b   Tamboise, Edouard ^c   Salzmann, Jean Loup ^c   Klatzmann, David ^a,d  

^a SORBONNE UNIVERSITÉ   (France)

^b Génopoïétic ^*  (France)

^c AVICENNE HOSPITAL   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Gene therapy; Nonviral vector; Plasmovirus; Retroviral vector; Thymidine kinase

Indexed keywords

GAG PROTEIN; MESSENGER RNA; THYMIDINE KINASE;

ANIMAL; ARTICLE; CELL CULTURE; CELL STRAIN 3T3; DNA REPLICATION; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; HERPES SIMPLEX VIRUS; HUMAN; METABOLISM; METHODOLOGY; MOUSE; PLASMID; PROVIRUS; TRANSGENE; VIRUS DNA CELL DNA INTERACTION; VIRUS GENE;

3T3 CELLS; ANIMALS; DNA REPLICATION; GENE EXPRESSION; GENE PRODUCTS, GAG; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, VIRAL; GENETIC VECTORS; HUMANS; MICE; PLASMIDS; PROVIRUSES; RNA, MESSENGER; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSGENES; TUMOR CELLS, CULTURED; VIRUS INTEGRATION;

EID: 0031230148     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kotin RM. Prospects for the use of adeno-associated virus as vector for human gene therapy. Human Gene Ther. 1994;5:793-801.
2. Miller AD, Rosman FJ. Improved retroviral vectors for gene transfer and expression. Biotechniques. 1989;7:980-990.
3. Mulligan RC. Development of new mammalian transducing vectors. In: Gluzman Y, ed. Eukaryotic Viral Vectors. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1982:133-143.
4. Takeuchi Y, Cosset F-L, Lachman PJ, et al. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J Virol. 1994;68:8001-8007.
5. Noguiez-Hellin P, Robert-le Meur M, Laune S, et al. Generation of a transcomplementable defective recombinant provirus transducing a foreign gene. C R Acad Sci Paris, Sciences de la Vie. 1996;319:45-50.
6. Noguiez-Hellin P, Robert-le Meur M, Salzmann J-L, et al. Plasmoviruses: nonviral/viral vectors for gene therapy. Proc Natl Acad Sci USA. 1996;93:4175-4180.
7. Caruso M, Panis Y, Gagandeep S, et al. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci USA. 1993;90:7024-7028.
8. Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA. 1988;85:6460-6464.
9. Boussif O, Lezoualc'h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA. 1995;92:7297-7301.
10. Goff S, Traktman P, Baltimore D. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J Virol. 1981;38:239-248.
11. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A Laboratory Manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
12. Wagner MJ, Sharp JA, Summers WC. Nucleotide sequence of the thymidine kinase gene of herpes simplex virus type 1. Proc Natl Acad Sci USA. 1981;78:1441-1445.
13. Shinnick TM, Lerner RA, Sutcliffe JG. Nucleotide sequence of Moloney murine leukemia virus. Nature. 1981; 293:543-548.
14. Towbin H, Staehelin T, Gordon T. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979;76:4350-4354.
15. Freeman SM, Abboud CN, Whartenby KA, et al. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 1993;53: 5274-5283.
16. Beck C, Cayeu S, Lupton SD, et al. The thymidine kinase/ ganciclovir-mediated "suicide" effect is variable in different tumor cells. Human Gene Ther. 1995;6:1525-1530.